Greehey CCRI Seminar Series – Fall ’25: Stanton McHardy, PhD (UTSA)
Share This Event
Share This Event
Keywords: synthetic chemistry, medicinal chemistry, pre-clinical drug discovery strategies, outsourcing, business development, and project management
Research interests:
Dr. McHardy’s lab and the CIDD are focused on medicinal chemistry research in the design, synthesis, and development of small-molecule compounds across multiple therapeutic disease areas. Currently funded programs are focused on the development of novel small molecules for breast, ovarian, and brain cancers, metabolic diseases, Schistosomiasis, biofilm inhibition, and dengue virus. The lab also focuses on developing new synthetic methodologies for synthesizing drug-like compounds and natural products.